About
Contact & Profiles
A5011196177
Research Areas
- Acute Ischemic Stroke Management
- Cerebrovascular and Carotid Artery Diseases
- Pediatric Hepatobiliary Diseases and Treatments
- Intracranial Aneurysms: Treatment and Complications
- CRISPR and Genetic Engineering
- Cardiovascular Health and Disease Prevention
- Drug Transport and Resistance Mechanisms
Mayo Clinic in Florida
2024-2025
Jacksonville College
2024
Cincinnati Children's Hospital Medical Center
2022
10.1016/j.avsg.2024.12.074
article
EN
Annals of Vascular Surgery
2025-01-01
The truncating mutations in tight junction protein 2 (TJP2) cause progressive cholestasis, liver failure, and hepatocyte carcinogenesis. Due to the lack of effective model systems, there are no targeted medications for pathology with TJP2 deficiency. We leveraged technologies patient-specific induced pluripotent stem cells (iPSC) CRISPR genome-editing, we aim establish a disease which recapitulates phenotypes patients
10.1016/j.jhepr.2022.100446
article
EN
cc-by
JHEP Reports
2022-02-01
10.1016/j.avsg.2024.12.004
article
EN
Annals of Vascular Surgery
2024-12-01
Coming Soon ...